Purchase Order 36C25226P0105
- Not listed
- Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor, was awarded a firm fixed-price purchase order valued at $2.0 million by Veterans Integrated Service Network 12 (VISN 12) on December 15, 2025, for the supply of Lenalidomide/Revlimid. The contract, which carries no set-aside designation and was awarded through open competitive procurement, will be performed at the awardee's Boca Raton facility with delivery to the VA facility in Danville,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $3 million firm fixed-price purchase order to Exelan Pharmaceuticals Inc. for the supply of generic lenalidomide. The contract, awarded on December 15, 2025, with an ultimate completion date of December 14, 2026, will be performed in Boca Raton, Florida. No set-aside designation was used in this competitive procurement, allowing Exelan to compete openly for the award. Lenalidomide is an immunomodulatory...
- Exelan Pharmaceuticals Inc., a pharmaceutical manufacturing and distribution company based in Boca Raton, Florida, was awarded a firm fixed-price delivery order by Veterans Integrated Service Network 20 (VISN 20) on November 3, 2025, for the supply of Lenalidomide. The contract ceiling value is $1.28M with an ultimate completion date of September 30, 2026. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) with no set-aside designation,...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a delivery order contract valued at $193,101.16 to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 20mg to support emergency pharmacy operations. The award, issued on November 13, 2025, is structured as a firm fixed-price delivery order with performance completion targeted for September 30, 2026. Exelan Pharmaceuticals will deliver the medication to a location in Boca Raton, Florida. This contract...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $29,090.18 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 10mg and 20mg tablets. The contract, which carries an ultimate completion date of February 3, 2026, was awarded on December 3, 2025, with no set-aside designation. Performance will be executed at Exelan's facility in Boca Raton, Florida. This delivery order falls under the GSA Federal Supply Schedule...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a delivery order valued at $4.77M to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide Capsules. This firm fixed-price contract, awarded on December 8, 2025, with an ultimate completion date of December 7, 2026, was issued without a set-aside designation, allowing full and open competition. The contract is performed in Boca Raton, Florida, where Exelan maintains its pharmaceutical manufacturing and...
- On December 11, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $39,663 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for emergency pharmaceutical supplies. The contract calls for the delivery of Lenalidomide 10mg tablets (21 count) and Lenalidomide 15mg bottles, with two orders each of the specified National Drug Codes (76282-0698-48 and 76282-0699-47). The work is to be performed in Boca Raton, Florida, with an ultimate completion...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 21, a civilian federal agency, to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract is for the delivery of 14 units of the pharmaceutical drug Lenalidomide 25mg Capsules, an emergency pharmacy item. The award has a ceiling value of $6,558.02 and a performance period that runs through November 15, 2025. The contract is not set...
- Exelan Pharmaceuticals Inc. was awarded a delivery order valued at $46,114.82 by Veterans Integrated Service Network 21 (VISN 21), a civilian division of the Department of Veterans Affairs, on November 17, 2025. The contract covers the supply of Lenalidomide in 10 mg and 15 mg formulations (NDCs 76282-0698-48 and 76282-0699-47) with an ultimate completion date of January 17, 2026. This firm fixed-price delivery order is not designated as a set-aside contract and is performed at the...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 23, awarded a delivery order to Exelan Pharmaceuticals Inc. on December 1, 2025, for the supply of Lenalidomide Capsules. This firm fixed-price delivery order carries a ceiling value of $1.21M and is scheduled for completion by September 30, 2026. The award was made without set-aside designation under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allowing Exelan to compete openly against other...
Exelan Pharmaceuticals Inc., a Boca Raton, Florida-based pharmaceutical manufacturer and distributor, was awarded a $1 million firm fixed-price purchase order by the Department of Veterans Affairs Veterans Integrated Service Network 10 on December 15, 2025, for the supply of Lenalidomide/Revlimid doses. The contract carries an ultimate completion date of December 14, 2026, and will be performed at the company's facility in Boca Raton, Florida. No set-aside designation was applied to this procurement. Exelan Pharmaceuticals specializes in manufacturing, distributing, and repackaging generic and branded pharmaceutical products for federal healthcare systems, including the VA, Department of Defense, Bureau of Prisons, and Indian Health Service, and maintains active registration in the System for Award Management through July 30, 2026. The underlying solicitation originated as a Sources Sought notice from VA Medical Center Oscar G. Johnson in Iron Mountain, Michigan, issued on October 30, 2025, for a one-time procurement of brand-name Lenalidomide (Revlimid), an oral immunomodulatory medication used to treat blood cancers. The Sources Sought notice was open to both small and other-than-small businesses under NAICS Code 325412, with a 12-month performance period for delivery to the facility's Pharmacy Department. Exelan's substantial experience supplying branded and generic pharmaceuticals to VA and other federal healthcare entities, combined with its existing federal contract portfolio and registered status, positioned the company to successfully meet the government's requirement for this critical oncology medication.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Lenalidomide (Revlimid) Dose-Brand name only | 36C25226Q0072 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 | Pre-Solicitation 1/4 | 10/30/25, 3:57 PM | |
6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920) | 36C25226Q0072 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 | Award Notice 4/4 | 12/10/25, 2:06 PM | |
Lenalidomide/Revlimid Dose - Brand Name or Equal | 36C25226Q0072 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 | Solicitation 2/4 | 11/17/25, 4:36 PM | |
6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920) | 36C25226Q0072 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 | Pre-Solicitation 3/4 | 11/21/25, 10:35 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0m | 12/10/25 |